Men diagnosed with prostate cancer can feel enormous pressure to treat it aggressively… even if they’re diagnosed at an early stage, where it hasn’t metastasized.
And that’s quite tragic.
For one, undergoing prostate cancer treatment—surgery, radiation, or hormone therapy—can make life downright miserable. They often come with gruesome complications, including incontinence and erectile dysfunction.
And now, a brand-new study questions whether these harsh treatments actually improve survival rates at all!
Let’s dive in…
High occurrence—but high survival
Since September is Prostate Awareness Month, there’s no better time to reassess the problem and talk about your options.
Because, when it comes to prostate cancer, there’s no denying the high occurrence rates.
In fact, one in nine men will develop it in their lifetime, making it the second-leading cause of cancer in men worldwide.
But remember—it’s a very SLOW growing form of cancer, so the survival rates are more optimistic.
In fact, only one in 41 men will actually die from prostate cancer, making its long-term prognosis among the VERY BEST of all cancers! Plus, most men diagnosed with prostate cancer will die with the disease… not because of it.
Despite these encouraging and well-established outcomes, many prostate cancer victims still feel intense pressure to undergo aggressive (and costly) treatments that wreak havoc on their lives.
That includes prostatectomies, external beam radiation, and hormone therapy.
Well, researchers finalized analyzed the long-term benefit (or lack thereof) of these treatments…
No significant difference
Researchers followed 1,600 men diagnosed with prostate cancer in the United Kingdom between 1999 and 2009. All subjects had localized disease (meaning the cancer hadn’t spread to other parts of the body).
At the start, the researchers randomly assigned the men to one of three groups…
The first group had surgery to remove the prostate (prostatectomy). The second received radiation therapy and hormone blockers. And the third group underwent “active monitoring” or “active surveillance.” (Notably, those in the “active monitoring” group could switch groups at any point, if their cancer progressed to the point of warranting treatment.)
Next, the researchers followed the men for approximately 15 years.
It turns out, by 2020, about three percent of the men from all three groups (45 men total) died of prostate cancer. But the truly eye-opening finding is this…
There was NO significant difference in the number of cancer deaths among any of the three groups!
Which means men who underwent radical surgery to remove the prostate… or had their manhood zapped with radiation and hormone therapy… did NOT improve their survival rates one iota compared to men who received no treatment outside of regular check-ins with their doctors.
To read more, check out the current issue of my monthly Logical Health Alternatives newsletter. (This month, I also talk about Alzheimer’s, psoriasis, and MORE!)
To log in, go to the “Subscribers” tab on my website, www.DrPescatore.com, and scroll down to the September 2023 articles. Not yet a subscriber? Click below to become one.
“Most men with prostate cancer can avoid or delay harsh treatments, long-term study confirms.” CNN Health, 3/12/23. (cnn.com/2023/03/11/health/prostate-cancer-surveillance-survival/index.html)